An Open-label, Multi-center, Phase Ib Clinical Trial of Chidamide Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphoma Patients
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Tucidinostat (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Peripheral T-cell lymphoma
- Focus Adverse reactions
- Sponsors Chipscreen Biosciences
- 20 Jul 2017 Planned primary completion date changed from 1 Jul 2019 to 1 Aug 2019.
- 20 Jul 2017 Status changed from not yet recruiting to recruiting.
- 05 Jul 2016 New trial record